Dapagliflozin And Saxagliptin Tablet, Film Coated
Product Images NDC 72205-438

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dapagliflozin And Saxagliptin (NDC 72205-438). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dapa-saxa-30s-count-container-label (Dapa Saxa 30s Count Container Label)

Dapa-saxa-30s-count-container-label (Dapa Saxa 30s Count Container Label)
Label for Dapagliflozin and Saxagliptin Tablets 10 mg / 5 mg, oral film-coated tablets in a 30-count package. The label states Rx only, includes storage instructions, manufacturer MSN Laboratories Private Limited in India, and distributor Novadoz Pharmaceuticals LLC, Piscataway, NJ. Contact phone number 855-NOVADOZ is shown along with a barcode.*
FDA Label Image

Dapa-saxa-90s-count-container-label (Dapa Saxa 90s Count Container Label)

Dapa-saxa-90s-count-container-label (Dapa Saxa 90s Count Container Label)
Label for Dapagliflozin and Saxagliptin Tablets 10 mg / 5 mg by Novadoz Pharmaceuticals LLC. The label states the product contains 90 film-coated tablets in oral dosage form. Manufacturer is MSN Laboratories Private Limited, India. Includes storage instructions and pharmacist dispensing guidance. Barcodes and NDC 72205-438-02 are visible.*
FDA Label Image

Dapa-saxa-dapagliflozin-structure (Dapa Saxa Dapagliflozin Structure)

Dapa-saxa-dapagliflozin-structure (Dapa Saxa Dapagliflozin Structure)
Chemical structure diagram depicting the molecular formula of Dapagliflozin, one of the active ingredients in the combination drug Dapagliflozin and Saxagliptin. The structure shows rings and functional groups including hydroxyl, chlorine, and ethoxy substitutions.*
FDA Label Image

Fig-1 (Dapa Saxa Figure 1)

Fig-1 (Dapa Saxa Figure 1)
A scatter plot showing the concentration-effect relationship between dapagliflozin dose (mg, logarithmic scale) and change from baseline in 24-hour urinary glucose (g). Observed values are plotted for healthy subjects and subjects with type 2 diabetes mellitus (T2DM) along with fitted dose-response lines for each group.*
FDA Label Image

Dapa-saxa-saxagliptin-stucture. (Dapa Saxa Saxagliptin Stucture)

Dapa-saxa-saxagliptin-stucture. (Dapa Saxa Saxagliptin Stucture)
Chemical structure of dapagliflozin and saxagliptin showing molecular bonds and functional groups including amine, hydroxyl, carbonyl, and cyano groups. The structure includes hydrochloride and dihydrate components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.